Mahesh Thakkar

Title: Mahesh Thakkar: Innovator in Fused Bicyclic Compounds

Introduction

Mahesh Thakkar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on fused bicyclic compounds. His research focuses on the development of compounds that serve as inhibitors of GPR91, a receptor involved in various medical conditions.

Latest Patents

Mahesh Thakkar holds a patent for "Fused bicyclic compounds, compositions and applications thereof." This patent describes fused bicyclic compounds that are effective inhibitors of GPR91. The compounds, along with their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions, are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to the inhibition of GPR91. He has 1 patent to his name.

Career Highlights

Thakkar is currently associated with Impetis Biosciences Limited, where he continues to advance his research in the pharmaceutical field. His work has the potential to impact the treatment of various diseases, making him a valuable asset to the company and the scientific community.

Collaborations

Some of his notable coworkers include Nadim Shaikh and Shailesh Shinde, who contribute to the collaborative efforts at Impetis Biosciences Limited.

Conclusion

Mahesh Thakkar's innovative work in the development of fused bicyclic compounds highlights his significant role in advancing medical science. His contributions are paving the way for new treatments and therapies, showcasing the importance of innovation in the pharmaceutical industry.